Parallel Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13
Closed -$65 3605
2025
Q2
$65 Sell
13
-86
-87% -$374 ﹤0.01% 3481
2025
Q1
$437 Buy
99
+79
+395% +$371 ﹤0.01% 3256
2024
Q4
$93 Sell
20
-17
-46% -$93 ﹤0.01% 3439
2024
Q3
$257 Hold
37
﹤0.01% 3263
2024
Q2
$289 Hold
37
﹤0.01% 3159
2024
Q1
$263 Hold
37
﹤0.01% 3130
2023
Q4
$248 Buy
+37
New +$208 ﹤0.01% 3146
2023
Q3
Sell
-51
Closed -$340 3417
2023
Q2
$282 Buy
51
+19
+59% +$102 ﹤0.01% 3199
2023
Q1
$200 Sell
32
-100
-76% -$557 ﹤0.01% 3276
2022
Q4
$615 Sell
132
-112
-46% -$552 ﹤0.01% 2994
2022
Q3
$1K Hold
244
﹤0.01% 2906
2022
Q2
$1K Sell
244
-108
-31% -$1.2K ﹤0.01% 2765
2022
Q1
$7K Sell
352
-684
-66% -$15.7K ﹤0.01% 2162
2021
Q4
$34K Sell
1,036
-2,500
-71% -$101K ﹤0.01% 1536
2021
Q3
$145K Sell
3,536
-10,167
-74% -$369K 0.01% 829
2021
Q2
$493K Sell
13,703
-3,365
-20% -$124K 0.02% 388
2021
Q1
$666K Sell
17,068
-1,726
-9% -$77.6K 0.03% 301
2020
Q4
$758K Buy
+18,794
New +$863K 0.04% 254

Other funds holding GDRX

Parallel Advisors's GDRX Position: Q3 2025 in Review

Parallel Advisors sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 13 shares — an estimated $65 sold.

Parallel Advisors first reported a position in GDRX in Q4 2020 and held it in 18 quarters. The position peaked at $758K in Q4 2020. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • Parallel Advisors reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • Parallel Advisors sold 13 GoodRx Holdings shares in Q3 2025, an estimated $65.
  • Parallel Advisors first reported a position in GoodRx Holdings in Q4 2020 and held it in 18 quarters.
  • Parallel Advisors's GoodRx Holdings position peaked at $758K in Q4 2020.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Parallel Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.